NASDAQ:MDAS

(MDAS) (MDAS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$31.35
$31.35
50-Day Range
N/A
52-Week Range
$17.00
$31.35
Volume
N/A
Average Volume
1.79 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MDAS stock logo

About (MDAS) Stock (NASDAQ:MDAS)

MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.

MDAS Stock News Headlines

Massive breakthrough for options traders.
A 34 year old man from central florida has uncovered a totally new way to trade options… Already this year it’s allowed real people to capture top returns of 50%... 100%... Even 200% overnight… Without using technical patterns, momentum, A.I. or any of the other commonly used strategies… Now, it’s important to mention that nothing is 100% perfect in terms of trading.
Massive breakthrough for options traders.
A 34 year old man from central florida has uncovered a totally new way to trade options… Already this year it’s allowed real people to capture top returns of 50%... 100%... Even 200% overnight… Without using technical patterns, momentum, A.I. or any of the other commonly used strategies… Now, it’s important to mention that nothing is 100% perfect in terms of trading.
FG Recovers N57Bn Debt from 10 MDAs
NCDMB, SON most efficient MDAs — FG
See More Headlines
Receive MDAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MDAS) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/29/2015
Today
4/29/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDAS
CUSIP
58404510
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

MDAS Stock Analysis - Frequently Asked Questions

How were (MDAS)'s earnings last quarter?

(MDAS) (NASDAQ:MDAS) announced its quarterly earnings data on Wednesday, July, 29th. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.04. The technology company earned $190.40 million during the quarter, compared to analysts' expectations of $187.45 million. The firm's revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.30 earnings per share.

What other stocks do shareholders of (MDAS) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MDAS) investors own include CVS Health (CVS), Home Depot (HD), StoneMor (STON), Blackstone (BX), NVIDIA (NVDA), AbbVie (ABBV), Broadcom (AVGO), Cadence Design Systems (CDNS), DexCom (DXCM) and The Goldman Sachs Group (GS).

This page (NASDAQ:MDAS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners